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Edited by Veli-Pekka LehtoAbstract Diﬀerent C-terminal fragments of parathyroid hor-
mone (PTH)-(1–84) in blood participate in the regulation of cal-
cium homeostasis by PTH-(1–84), and an antagonizing eﬀect for
the large carboxyl-terminal parathyroid hormone (C-PTH)-
fragment (7–84) on calcium release has been described in vivo
and in vitro. In this study the smaller C-PTH-fragment (53–
84) and mid-regional PTH fragment (28–48), which represent
discrete areas of activity in the PTH-(7–84) molecule, were as-
sayed for their eﬀects on calcium release and alkaline phospha-
tase (ALP) activity in a chick bone organ culture system.
Neither PTH-(28–48) nor PTH-(53–84) had any eﬀect on cal-
cium release into the medium and both fragments stimulated
ALP activity in the bone tissue, suggesting that the cAMP/
PKA signalling pathway was not aﬀected by these fragments.
However they suppressed the calcium release induced by PTH-
(1–34) and attenuated the down regulation of ALP activity
caused by PTH-(1–34), suggesting that the eﬀect on the
cAMP/PKA signalling pathway may be indirectly. In conclusion,
the study shows that the PTH-fragments (53–84) and (28–48)
antagonize the PTH-(1–34) induced eﬀects on calcium release
and inhibition of ALP activity in a chick bone organ culture sys-
tem.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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It is well known that parathyroid hormone (PTH) is metab-
olized in vivo and that smaller PTH fragments of diﬀerent sizes
circulate in the blood. Until recently, the physiological rele-
vance of these fragments has often been overlooked but it is
now known that the carboxyl-terminal parathyroid hormone
(C-PTH) fragments are involved in the regulation of calcium
homeostasis and represent a new ﬁeld of investigation of
PTH biology. The peptide hPTH-(7–84) was shown in vivo
to antagonize the increase in serum calcium level induced by
hPTH-(1–34) and hPTH-(1–84). In addition a mixture, better
representing the in vivo situation, containing 10% hPTH-(7–*Corresponding author. Fax: +49 531 6181 202.
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doi:10.1016/j.febslet.2006.01.07684) and 45% hPTH-(53–84) and 45% hPTH-(39–84) has been
shown to have an antagonistic eﬀect on PTH-(1–34) induced
hypercalcemia [1]. Furthermore, infusion of hPTH-(7–84)
alone was shown to decrease serum calcium concentration in
a short term parathyroidectomized rat model (PTX) [1], but
had no eﬀect in a more chronic parathyroidectomized renal
failure rat model (PTX-Nx) [2]. The in vivo anti-resorbtive
and antagonistic eﬀect of PTH-(7–84) have been conﬁrmed
in bone tissue culture [3] and it is now largely accepted that
the smaller C-PTH fragments are actively involved in calcium
regulation.
The small N-terminally truncated PTH-fragments have also
been shown to elicit a number of biological eﬀects on bone
cells, frequently contrary to those of the intact N-terminal
PTH peptides. The mid-regional fragment PTH-(28–48) aug-
ments cell proliferation in bone forming cells in vivo [4] and
in vitro in chondrocytes [5] and osteoblasts [6,7]. It also in-
duces alkaline phosphatase (ALP) activity and osteocalcin
mRNA expression in osteoblast-like cells [8] and collagen II
gene expression in chondrocytes [9]. The C-terminal fragment
PTH-(53–84) induces also ALP activity in bone cells and
regulates calcium inﬂux in chondrocytes [10]. Simultaneous
exposure of cells and tissues to these PTH-fragments has been
shown to modulate the changes in proliferation and diﬀerenti-
ation induced by PTH-(1–34) [11–13]. From these studies it is
apparent that the N-, C- and mid-regional PTH-fragments are
biologically active on bone cells and are involved in the
regulation of bone metabolism. The aim of this study was
therefore, to further elucidate the role of the small fragments
(53–84) and (28–48), which represent discrete elements within
the larger fragment PTH-(7–84), on calcium metabolism and
ALP activity.2. Materials and methods
2.1. Chemicals
Na b-glycerophosphate, antibiotics, and 1,25(OH)2D3 were obtained
from Sigma (Deisenhofen, Germany). hPTH peptides were from Sigma
or Bachem or made in the chemical department of the institute and
solved in 10 mM acetic acid. Analytical chemicals were purchased from
Merck (Darmstadt, Germany). cAMP assay kits was obtained from
Amersham International (Braunschweig). Dulbecco’s modiﬁed Eagle’s
medium (DMEM) was purchased from Flow Laboratories (Mecken-
heim, Germany). Tissue culture plasticware was obtained from Tech-
nomara (Fernwald, Germany). Valo eggs were purchased from
Lohmann Tierzucht (Cuxhaven, Germany). The roller drum was con-
structed in our workshop at the GBF (Braunschweig).ation of European Biochemical Societies.
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The bone culture system has been described previously [12,15].
Brieﬂy, tibiae from 17-day-old chick embyros were transferred in
marked pairs to 4 ml serum-free DMEM, containing glutamine
(2 mmol/L), gentamycin (20 lg/ml), 1.8 mmol/L calcium, supple-
mented daily with 50 lg/ml ascorbate to a 10 ml plastic tube and ro-
tated in 2.5 turns/min at 37 C in a humidiﬁed atmosphere of 5%
CO2. After one day of culturing, the cultures were induced in pairs,
using the contra-lateral bone as control. Glucose and lactate concen-
trations were determined using an automatic glucose and lactate ana-
lyser (model 2000 YSI). During optimisation of the system, it was
found that the time-dependent response to PTH-(1–34) treatment de-
creased with increasing calcium concentrations (1.8, 2.2, 3, 4.29 mol/
L). The optimal concentration was found to be 1.8 mmol/L calcium
which was also close to the serum calcium concentration found in
embryonic chicks of 1.6 mmol/L. The values for calcium during the
culture period remained within ca 2% of the initial value from the sec-
ond day to the end of the culture and the values between the pairs re-
mained within 1.9% of each other.
2.3. Determination of calcium
Levels of calcium in the culture media were measured by atomic
absorption spectrophotometry (Perkin–Elmer). During the culture
every 24 h 50 ll aliquots were taken oﬀ and frozen and diluted with
2 ml of 0.2% lanthanum nitrate in 0.3% nitric acid (Suprapur, Merck)
and measured four times at 422.6 nm. The results are calculated as
micrograms calcium per millilitre supernatant and then expressed as
the diﬀerence between induced and non-induced pairs of bones.
2.4. Determination of alkaline phosphatase activity
Initially during the culture, for every 24 h, 50 ll aliquots were taken
oﬀ for measuring ALP. In addition, at the end of the culture normally
after 72 h ALP in the tissue has been determined and found to be more-10
-8
-6
-4
-2
0
2
4
6
8
10
12
14
µ
g
C
a
/m
l
1-
34
1-
84
53
-
84
28
-
48
3-
34C
***
***
x
Fig. 1. Inhibition by hPTH-(53–84) and PTH-(28–48) of calcium release indu
day-old chick embryos were cultured in 4 ml serum free DMEM in a rotatin
72 h. Bones were stimulated with the individual fragments at 10 nmol/L, Co
hPTH (3–34); in combination bones were pre-stimulated for 2 h with either h
by hPTH-(1–34) at 10 nmol/L. 1,25(OH)2D3 at 10 nmol/L; in combination b
hPTH-(28–48) at 10 nmol/L and stimulated by 1,25(OH)2D3 at 10 nmol/L. Bo
in combinations pre-stimulated with BP at 1 lmol/L and induced by hPTH(1–
72 h by atomic absorption spectrometry. Results are means of ﬁve bones ± S
and are calculated as micrograms calcium per ml of supernatant and then ex
values C vs. 1–34, 1–84, and BP are indicated *** <0.001 and C vs. 1,25(OH
48 + 1–34 are indicated · <0.05. The P values 1,25(OH)2D3(D3) vs. 53–84 + 1
The P value BP vs. BP+1–34 is indicated  <0.05.signiﬁcant. Tibiae were incubated with shaking overnight at 37 C in
2 ml 50 mmol N-tris (hydroxymethyl)methyl-2-aminoethanesulfonic
acid buﬀer, adjusted to pH 7.4 with NaOH, containing collagenase
(Worthington, CLS 2) (1.5 mg/ml, approximately 370 U). The bones
were removed and the extracts were then clariﬁed by centrifugation
at 12000 rpm for 10 min at 4 C. 10 ll aliquots were assayed for
ALP activity by incubating for 15 min with P-nitrophenyl phosphate
in alkaline buﬀer solution (No. 221, Sigma). The absorbance was then
measured at 405 nm. Results were measured as Sigma Units/min/L and
expressed in % of control of each treated/control bone pair.
For histological determination of ALP in bone tissue after 72 h in
culture, bones were either frozen at 70 C or used directly. 6–8 lm
sections were cut at 20 C and then stained with a fresh solution of
5 mg sodium naphthyl-phosphate and 10 mg Fast Red TR-salt in
10 ml in 0.1 M Tris–Cl, pH 8 for 10–30 min.
2.5. Determination of cAMP
To determine cAMP, the cultures were pre-treated for 25 min with
the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (1 mM)
followed by an additional 30 min incubation with the hPTH fragments.
The bones were pre-treated with the appropriate PTH fragments for
various times as indicated indicated in the text, followed by additional
incubation with hPTH-(1–34). The reaction was stopped by aspirating
the medium and washing the bones quickly with ice-cold PBS and
extracting cAMP overnight at 20 C with 95% ethanol acidiﬁed with
1% HCl. The samples were then dried under vacuum and dissolved in
800 ll PBS. 50 ll aliquots were removed and the cAMP content deter-
mined by a competitive binding assay using a commercially available
cAMP assay kit (Amersham, Braunschweig).
2.6. Statistics
All data were expressed as means ± S.E.M. Statistical signiﬁcance
was determined using Student’s t test The P values *P < 0.05 and
***P < 0.001 indicate statistical signiﬁcance.53
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ced by hPTH-(1–34) and 1,25(OH)2D3. Tibia in marked pairs from 17-
g roller drum and incubated in treatment groups of ﬁve bone each for
ntrols, C; hPTH-(1–34); hPTH-(1–84), hPTH-(53–84); hPTH-(28–48);
PTH-(53–84) at 10 nmol/L or hPTH-(28–48) at 10 nmol/L and induced
ones were pre-stimulated for 2 h either hPTH-(53–84) at 10 nmol/L or
nes were stimulated with bisphophonate BP (BM 210955) at 1 lmol/L,
34) at 10 nmol/L. The calcium in the supernatant was determined after
.E.M. The results are representative for three independent experiments
pressed as the diﬀerence between induced and un-induced pairs. The P
)2D3 is indicated
* <0.05. The P values 1–34 vs. 53–84 + 1–34, and 28–
,25(OH)2D3(D3) and 28–48 + 1,25(OH)2D3(D3) are indicated + <0.05.
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In this study we have used organ cultures of embryonic
chick tibiae [13] to determine the eﬀects of PTH fragments
hPTH-(53–84) and (28–48) on calcium level in the medium-15.00
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Fig. 2. Inhibition by hPTH-(53–84) and hPTH-(28–48) of calcium release at
2 h either with hPTH-(53–84) and hPTH-(28–48) at the indicated concentra
bones were stimulated alone by hPTH-(1–34) at the indicated concentration
expressed as the means of ﬁve bones ± S.E.M. The results are representative
calcium per millilitre of supernatant and then expressed as the diﬀerence betwe
*** <0.001 and * <0.05. The P values 1–34 vs. 28–48 + 1–34 are indicated ··
hPTH-(53–84) + hPTH-(1–34); hPTH-(28–48) + hPTH-(1–34).
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Fig. 3. Stimulation of ALP activity by hPTH-(53–84) and hPTH-(28–48) at
were induced by hPTH-(1–34) hPTH-(53–84) and hPTH-(28–48) at the indic
with hPTH-(53–84) and hPTH-(28–48) at the indicated concentrations and sti
assayed in the bone tissue. Results were measured as Sigma Units/min/L and
as the means of ﬁve bones ± S.E.M. The results are representative for three ind
The P values 1–34 vs. 53–84 and 28–48 are indicated · <0.05. The P values
hPTH-(1–34); hPTH-(53–84); hPTH-(28–48); hPTH-(53–84and ALP activity in the tissue. When 10 nM hPTH-(53–84),
hPTH-(28–48) and hPTH-(3–34) were added to the cultures,
no signiﬁcant eﬀect on calcium was observed whereas both
hPTH-(1–34) and hPTH-(1–84) at a concentration of 10 nM
induced a signiﬁcant release of calcium into the medium.***
***
*
x
1 10 100 nM
diﬀerent doses induced by hPTH-(1–34). Bones were pre-stimulated for
tions and stimulated by hPTH-(1–34) at 10 nmol/L. For comparison
s. The calcium concentration was determined after 72 h. Results are
for three independent experiments and are calculated as micrograms
en induced and un-induced pairs. The P values C vs. 1–34 are indicated
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xxx
xxx
+
+
10 100 nM
diﬀerent doses and suppression of inhibition by hPTH-(1–34). Bones
ated concentrations and in combinations pre-stimulated for 2 h either
mulated by hPTH-(1–34) at 10 nmol/L. After 72 h ALPase activity was
expressed in % of each treated/control bone pair. Results are expressed
ependent experiments. The P values C vs. 1–34 are indicated *** <0.001
1–34 vs. 53–84 +1–34 and 28–48 + 1–34 are indicated * <0.05.
) + hPTH-(1–34); hPTH-(28–48) + hPTH-(1–34).
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84) and hPTH-(28–48) for 2 h and then incubated with hPTH-
(1–34), the amount of calcium released into the medium after
72 h was signiﬁcantly reduced. The hPTH-(1–34)-induced cal-
cium release could also be reduced to basal levels by the addi-
tion of bisphosphonate, which also caused a reduction in
calcium released into the medium on its own. Furthermore,
both hPTH-(53–84) and hPTH-(28–48) also inhibited
1,25(OH)2D3 induced calcium release (Fig. 1).
The maximal doses of the antagonistic eﬀect of hPTH-(28–
48) and hPTH-(53–84) on hPTH-(1–34) induced calcium release
was investigated by preincubating with diﬀerent concentrations
of PTH fragment whilst maintaining hPTH-(1–34) at 10 nM
(Fig. 2). Pre-incubation with hPTH-(53–84) produced at diﬀer-
ent concentrations antagonism of the hPTH-(1–34) induced cal-
cium release with 0.1 nM hPTH-(53–84) reducing the eﬀect by
around 60% rising to around 90–95% with 10–100 nM hPTH-
(53–84). In contrast, pre-incubation with 100 nM hPTH-(28–Fig. 4. Histological determination of stimulation of ALP activity by hPT
incubation of bones at concentrations of 10 nmol/L with hPTH-(53–84) and h
70 C or directly sliced in 6–8 lm sections at 20 C. The sections were sta
Fast Red TR-salt in 10 ml 0,1 M Tris–Cl, pH 8) for 10–30 min. Arrowhead i
48); C, hPTH-(53–84); D, hPTH-(1–34).48) reduced hPTH-(1–34) induced calcium release by around
40% whereas concentrations with 1–0.1 nM hPTH-(28–48)
caused a strong reduction to below basal levels. In comparison
hPTH-(1–34) induced a dose-dependent increase in calcium re-
lease. To obtain an indication of their eﬀects on ALP activity
the bones were cultured after exposure to hPTH-fragments
for 72 h. Both hPTH-(53–84) and hPTH-(28–48) stimulated
ALP activity in the tissue, in an apparently non-dose-dependent
manner at the tested concentrations, with values of up to 140%
of the controls being seen at concentrations as low as 0.1 nM.
This was in contrast to hPTH-(1–34), which dose-dependently
inhibited ALP activity reaching a minimum of 20% of the con-
trol values at 100 nM (Fig. 3). The hPTH-(1–34) induced reduc-
tion in ALP activity was antagonised by hPTH-(53–84) and
hPTH-(28–48) in a similar manner to that seen with calcium re-
lease. Pre-incubation with hPTH-(28–48) abrogated the eﬀect
of 10 nM hPTH-(1–34) by 50% at all concentrations tested
(0.01–10 nM). Also hPTH-(53–84) reduced the eﬀect ofH-(53–84) and hPTH-(28–48) and inhibition by hPTH-(1–34). After
PTH-(28–48) and hPTH-(1–34) for 72 h the bones have been frozen at
ined with a fresh solution (5 mg sodium naphtyl-phosphate and 10 mg
ndicates ALP, KT indicates trabecular bone. A, control; B, hPTH-(28–
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Fig. 5. Time-dependent inhibition of cAMP accumulation by hPTH-(53–84) and hPTH-(28–48) stimulated by hPTH-(1–34). Bones were stimulated
with the individual fragments at 10 nmol/L. In combinations bones were pre-stimulated for various times as indicated either by hPTH-(53–84) at
10 nm/L or hPTH-(28–48) at 10 nmol/L and induced by hPTH-(1–34) at 10 nmol/L for 30 min. cAMP was determined as described. Results are
expressed as the means of ﬁve bones ± S.E.M. and are representative for four independent experiments. The P values C vs. 1–34, 53–84 + 1–34, and
28–48 + 1–34 are indicated *** <0.001.
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100 nM (Fig. 3). To conﬁrm these data, the bone were cryosec-
tioned and histochemically stained for ALP. Bones treated with
either hPTH-(53–84) or hPTH-(28–48) at 10 nM showed an in-
crease in the area of trabecular bone a positive staining for
ALP. In contrast, those treated with hPTH-(1–34) at 10 nM
showed an almost complete lack of staining for ALP compared
to the untreated control (Fig. 4). Similar results were also ob-
tained in sections of the epiphysis (data not shown).
To determine whether the hPTH fragments might be acting
by modulating cAMP signalling by type I PTH/PTHrP recep-
tor, tibiae were treated with 10 nM hPTH-(53–84) and hPTH-
(28–48) alone or in combination with hPTH-(1–34). Neither
hPTH-(53–84) nor hPTH-(28–48) alone had any eﬀect on
cAMP synthesis whereas treatment with 10 nM hPTH-(1–34)
gave rise to a signiﬁcant increase in cAMP accumulation after
30 min incubation. To get further insight into the antagonistic
role of the mid-regional and C-terminal fragment in the cAMP/
PKA signalling pathway, the eﬀect of pre-incubating the bones
with these fragments before challenging with hPTH-(1–34) was
examined. cAMP synthesis induced by hPTH-(1–34) was inhib-
ited after 1–6 h pre-incubation by 10 nM hPTH-(53–84) or
hPTH-(28–48) by around 70% and 62%, respectively (Fig. 5).4. Discussion
In this investigation we have demonstrated that the PTH
fragments, hPTH-(53–84) and hPTH-(28–48), antagonised the
eﬀects of hPTH-(1–34) on calcium release and ALP activity,
which are known to be cAMP mediated. In isolation, neither
hPTH-(53–84) nor hPTH-(28–48) had any aﬀect calcium re-
lease however, both peptides signiﬁcantly induced ALP activity
[13,14]. Calcium levels in the culture system were optimisedsuch that calcium release induced by PTH-(1–34) were maxi-
mised. The optimal calcium concentration for PTH-(1–34) in-
duced calcium release was found to be 1.8 mmol/L, consistent
with serum levels, however hPTH-(53–84) and hPTH-(28–48)
were not assayed under conditions of diﬀerent calcium concen-
trations. This is perhaps of relevance as the suppressive eﬀects
of the C-fragment hPTH-(7–84) have only been reported in
the PTX rat model [1] and not in the PTX-Nx [2] rat model sug-
gesting that the serum calcium concentration is an important
factor for the function of C-PTH-fragments. Further experi-
ments will be required to determine how calcium modulates
the eﬀects of PTH-(53–84) and (28–48).
Although both PTH fragments were shown to potently
antagonise the eﬀects of hPTH-(1–34) on calcium release and
ALP, hPTH-(28–48) was found to be considerably more active
in aﬀecting the calcium release than hPTH-(53–84). hPTH-
(53–84) produced an inhibition of the hPTH-(1–34) eﬀect with
maximal inhibition between 10 and 100 nM The antagonism
produced by hPTH-(28–48) was, in fact, dose-related, but in
an unexpected manner wherby lower doses exerted a greater
inhibitory eﬀect than did higher doses. This contrasts with
the more typical dose-dependence of the PTH-(53–84) eﬀect
and seems to imply that the two peptides have diﬀerent mech-
anisms of action. Interestingly both fragments induced ALP
activity in isolation, demonstrating that they are not simply in-
ert peptides that prevent the binding of hPTH-(1–34), which is
also supported by other studies both in vivo and in vitro [4–
10]. In this report we show that the fragments induced ALP
activity at low concentrations, whereas PTH-(1–34) signiﬁ-
cantly repressed ALP activity at concentrations of 0.1–
10 nM. The data demonstrate that in combination, low con-
centrations of either fragment could abolish the eﬀects of
10 nM PTH-(1–34) on calcium release and repression of
ALP activity. This ﬁnding that diﬀerent parts of the PTH
1514 C. Duvos et al. / FEBS Letters 580 (2006) 1509–1514molecule can exert opposing eﬀects at widely diﬀering concen-
trations suggests that distinct PTH-domains exert agonist and
antagonist actions on bone tissue and are consistent with other
ﬁndings, where low concentrations of PTH showed growth
enhancing activities in avian [15,16] and in other cellular sys-
tems [17,18]. For determine a dose related response for both
fragments a higher dilution may be required. The antagonistic
eﬀects of hPTH-(53–84) shown in this study are supported by
in vivo data showing that a fragment mixture containing
hPTH-(53–84) and hPTH-(7–84) in a PTX short term acute
rat model antagonizes PTH-(1–84) induced calcium release
[1]. The mechanism by which C-PTH fragments antagonize
PTH-(1–34) or hPTH-(1–84) eﬀects is not known. Since the
hPTH-fragments (53–84) and (28–48) including hPTH-(7–84)
do not have an eﬀect per se on cAMP synthesis, the suppres-
sive eﬀect may be the result of an indirect regulation of the type
I PTH/PTHRP receptor by the action of C-PTH-fragments on
the C-PTH receptor. Binding experiments have shown that C-
terminal PTH peptides can bind speciﬁcally and is equally dis-
placed by PTH-(7–84) and by PTH-(1–84), but only partially
displayed by PTH-(1–34) [19–21]. Binding data speciﬁc for
PTH-(53–84) have been demonstrated [22]. Activation of the
PLC/PKC pathway by PTH-(28–48) on primary cultures have
been reported [17], however on cells expressing the recombi-
nant type I PTH/PTHRP receptor the PTH-(28–48) was found
to be inactive [23]. Therefore more knowledge of the receptor
signalling pathway independent of the cAMP signalling and
the cross-talks of diﬀerent signalling pathways is required for
a better understanding of the reported biological data of M-
and C-PTH-fragments on the eﬀect of hPTH-(1–34) induced
cAMP/PKA signalling pathway. Furthermore the observation
of a suppressive eﬀect of these peptides on 1,25(OH)2 induced
calcium release is similar as described for hPTH-(7–84) [3]. The
mechanism remains obscure. It suggests, that PTH-fragments
might play a broader role in regulating bone metabolism.
In summary, we provide here the ﬁrst experimental support
for the action of small PTH-fragments (53–84) and (28–48) to
antagonize PTH-(1–34) eﬀects in regulation of bone metabo-
lism.
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